Skin-care business Galderma, which owns Cetaphil, has promoted Miles Harrison to president and general manager of Galderma Laboratories LP.
Harrison was previously vice president and general manager of the Galderma’s self medication business unit, where he oversaw a handful of new product launches — including Benzac Acne Solutions, Cetaphil Men, Cetaphil Baby, Excipial Skin Solutions and Qilib Hair Regrowth + Revitalization.
“Galderma is experiencing a tremendous amount of growth following the launch of eight new products across all three business units in the U.S. over the past 18 months,” chief executive officer Stuart Raetzman said. The company also owns Epiduo Gel, Differin Gel, Tri-Luma Cream and Restylane.
In the new role, Harrison will lead the company’s U.S. and Canada teams. He joined Galderma from Novartis in 2014.